Browse > Article
http://dx.doi.org/10.5010/JPB.2010.37.3.262

Plant-based production of therapeutic antibodies  

Kim, Young-Kwan (Department of Biological Science, College of Natural ciences, Wonkwang University)
So, Yang-Kang (Department of Biological Science, College of Natural ciences, Wonkwang University)
Park, Da-Young (Department of Biological Science, College of Natural ciences, Wonkwang University)
Kim, Hyun-Soon (Plant systems engineering research center, Korea Research Institute of Bioscience and Biotechnology)
Jeon, Jae-Heung (Plant systems engineering research center, Korea Research Institute of Bioscience and Biotechnology)
Choo, Young-Kug (Department of Biological Science, College of Natural ciences, Wonkwang University)
Ko, Ki-Sung (Department of Biological Science, College of Natural ciences, Wonkwang University)
Publication Information
Journal of Plant Biotechnology / v.37, no.3, 2010 , pp. 262-268 More about this Journal
Abstract
Antibodies are powerful and versatile tools to play a critical role in the diagnosis and treatment of many diseases. Their application has been enhanced significantly with the advanced recombinant DNA and heterologonous expression technologies, allowing to produce immunotherapeutic proteins with improved biofunctional properties. However, with currently available technologies, mammalian cell-based therapeutic antibody production, as an alternative for production in humans and animals, is often not plentiful for passive immunotherapeutics in treatment of many diseases. Recently, plant expression systems for therapeutic antibodies have become well-established. Thus, plants have been considered to provide an attractive alternative production system for therapeutic antibodies, as plants have several advantages such as the lack of human pathogens, and low cost of upstream production and flexible scale-up of highly valuable recombinant glycoproteins. Recent advances in modification of posttranslational processing for human-like glycosylation in transgenic plants will make it possible that plant can become a suitable protein expression system over the animal cellbased current production system. This review will discuss recent advances in plant expression technology and issues for their application to therapeutic antibody production.
Keywords
ADCC; glycosylation; plant-derived pharmaceuticals; therapeutic protein;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Melo NS, Nimtz M, Conradt HS, Fevereiro PS, Costa J (1997) Identification of the human Lewis(a) carbohydrate motif in a secretory peroxidase from a plant cell suspension culture (Vaccinium myrtillus L.). FEBS Lett 415:186-191   DOI
2 Miele L (1997) Plants as bioreactors for biopharmaceuticals:regulatory considerations. Trends Biotechnol 15:45-50   DOI
3 Pen J (1996) Comparison of host systems for the production of recombinant proteins. In Transgenic plants:a production system for industrial and pharmaceutical proteins. John Wiley and Sons Ltd 149-167
4 Priem B, Gitti R, Bush CA, Gross KC (1993) Structure of ten free N-glycans in ripening tomato fruit. Plant Physiol 102:445-458   DOI
5 Ruf S, Hermann M, Berger IJ, Carrer H, Bock R (2001) Stable genetic transformation of tomato plastids and expression of a foreign protein in fruit. Nat Biotechnol 19:870-875   DOI
6 Shah MM, Fujiyama K, Flynn CR, Joshi L (2003) Sialylated endogenous glycoconjugates in plant cells. Nat Biotechnol 21:1470-1471   DOI
7 Jefferis R, Lund J, Pound JD (1998) IgG-Fc-mediated effector functions:molecular definition of interaction sites for effector ligands and the role of glycosylation. Immunol Rev 163:50-76
8 Ko K, Steplewski Z, Glogowska M, Koprowski H (2005) Inhibition of tumor growth by plant-derived mAb. Proc Natl Acad Sci USA 102:7026-7030   DOI
9 Ko K, Koprowski H (2005) Plant biopharming of monoclonal antibodies. Virus Res 111:93-100   DOI
10 Ko K, Tekoah Y, Rudd PM, Harvey DJ, Dwek RA, Spitsin S, Hanlon CA, Rupprecht C, Dietzschold B, Golovkin M, Koprowski H (2003) Function and glycosylation of plantderived antiviral monoclonal antibody. Proc Natl Acad Sci USA 100:8013-8018   DOI
11 Kornfeld R, Kornfeld S (1985) Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem 54:631-664   DOI
12 Kermode AR (1996) Mechanisms of intracellular protein transport and targeting in plant cells. Crit Rev Plant Sci 15:285-423   DOI
13 Koziel MG, Carozzi NB, Desai N (1996) Optimizing expression of transgenes with an emphasis on post-transcriptional events. Plant Mol Biol 32:393-405   DOI
14 Kuby J (1997) Immunology. Third Edition. W. H. Freeman and Company, New York. 664.
15 Kusnadi, AR, Evangelista RL, Hood EE, Howard J, Nikolov ZL (1998) Production and purification of two recombinant proteins from transgenic corn. Biotechnol Progress 14:149-155   DOI
16 Lerouge P, Cabanes-Macheteau M, Rayon C, Fischette-Laine AC, Gomord V, Faye L (1998) N-glycosylation biosynthesis in plants:recent developments and future trends. Plant Mol Biol 38:31-48   DOI
17 Faye L, Johnson KD, Sturm A, Chrispeels MJ (1989) Structure, biosynthesis, and function of asparagine-linked glycans on plant glycoproteins. Physiologia Plantarum 75:309-314   DOI
18 Fitchette AC, Gomord V, Chekkafi A, Faye A (1994) Distribution of xylosylation and fucosylation in the plant Golgi apparatus. Plant J 5:673-682   DOI
19 Fitchette AC, Cabanes-Macheteau M, Marvin L, Martin B, Satiat-Jeunemaitre B, Gomord V, Crooks K, Lerouge P, Faye L, Hawes C (1999) Biosynthesis and immunolocalization of Lewis a-containing N-glycans in the plant cell. Plant Physiol 121:333-344   DOI
20 Fitchette AC, Gomord V, Cabanes M, Michalski JC, Saint Macary M, Foucher B, Cavelier B, Hawes C, Lerouge P, Faye L (1997) N-glycans harboring the Lewis a epitope are expressed at the surface of plant cells. Plant J 12:1411-1417   DOI
21 Fraley RT, Rogers SG, Horsch RB, Sanders PR, Flick JS, Adams SP, Bittner ML, Brand LA, Fink CL, Fry JS, Galluppi GR, Goldberg SB, Hoffmann NL, Woo SC (1983) Expression of bacterial genes in plant cells. Proc Natl Acad Sci USA 80:4803-4807   DOI
22 Gomord W, Chamberlain P, Jefferis R, Faye L (2005) Biopharmaceutical production in plants:problems, solutions and opportunities. Trends in Biotechno 23:559-565   DOI
23 Horsch RB, Fraley RT, Rogers SG, Sanders PR, Lloyd A, Hoffman N (1984) Inheritance of functional foreign genes in plants. Science 223:496-498   DOI
24 Jamal A, Ahn MH, Song M, Oh EY, Hong J, Choo YK, Ko K, Han YS, Oh SH, Van Der Linden J, Leusen JH, Ko K (2009) Biological Validation of Plant-Derived Anti-Human Colorectal Cancer Monoclonal Antibody CO17-1A. Hybridoma 28:7-12   DOI   ScienceOn
25 Brodzik R, Glogowska M, Bandurska K, Okulicz M, Deka D, Ko K, van der Linden J, Leusen JH, Pogrebnyak N, Golovkin M, Steplewski Z, Koprowski H (2006) Plant-derived anti-Lewis Y mAb exhibits biological activities for efficient immunotherapy against human cancer cells. Proc Natl Acad Sci USA 103:8804-8809   DOI
26 Conrad U, Fiedler U, Artsaenko O, Phillips J (1998) High-level and stable accumulation of single-chain Fv antibodies in plant storage organs. J Plant Physiol 152:708-711   DOI   ScienceOn
27 Cabanes-Macheteau M, Fitchette-Lainé AC, Loutelier-Bourhis C, Lange C, Vine ND, Ma JK, Lerouge P, Faye L (1999) N-Glycosylation of a mouse IgG expressed in transgenic tobacco plants. Glycobiology 9:365-372   DOI
28 Capon C, Piller F, Wieruszeski JM, Leroy Y, Fournet B (1990) Structural analysis of the carbohydrate chain isolated from jacalin lectin. Carbohydr Res 199:121-127   DOI
29 Conrad U, Fiedler U (1998) Compartment-specific accumulation of recombinant immunoglobulins in plant cells:an essential tool for antibody production and immunomodulation of physiological functions and pathogen activity. Plant Mol Biol 38:101-109   DOI
30 D’Andrea G, Bouwstra B, Kamerling JP, Vliegenhart JFG (1988) Primary structure of the xylose-containing N-linked carbohydrate moiety from ascorbic acid oxidase of Cucurbita pepo medullosa. Glycoconj J 5:151-157   DOI
31 Daniell H (2002) Molecular strategies for gene containment in transgenic crops. Nat Biotechnol 20:581-586
32 De Wilde C, Van Houdt H, De Buck S, Angenon G, De Jaeger G, Depicker A (2000) Plants as bioreactors for protein production: avoiding the problem of transgene silencing. Plant Mol Biol 43:347-359
33 Doran P (2000) Foreign Protein Production in Plant Tissue Cultures. Current Opinion in Biotechnology 11:199-204   DOI
34 Bakker H, Bardor M, Molthoff JW, Gomord V, Elbers I, Stevens LH, Jordi W, Lommen A, Faye L, Lerouge P, Bosch, D (2001) Galactose-extended glycans of antibodies produced by transgenic plants. Proc Natl Acad Sci USA 98:2899-2904   DOI
35 Armour, KL, Clark MR, Hadley AG, Williamson LM (1999) Recombinant human IgG molecules lacking Fc-gamma Receptor I binding and monocyte triggering activities. Eur J Immunol 29:2613-2624   DOI
36 Ashford DA, Dwek RA, Welply JK, Amatayakul S, Homans SW, Lis H, Taylor GN, Sharon N, Rademacher, TW (1987) The ${\beta}-1{\rightarrow}2-D-xylose$ and ${\alpha}-1{\rightarrow}3-L-fucose$ substituted N-linked oligosaccharides from Erythrina cristagalli lectin. Eur J Biochem 166:311-320   DOI
37 Breedveld FC (2000) Therapeutic monoclonal antibodies. Lancet 355:735-740   DOI
38 Balen B, Krsnik-Rasol M, Zamfir AD, Milo J, Vakhrushev SY, Peter-Katalini J (2006) Glycoproteomic survey of Mammillaria gracillis tissues grown in vitro. J Proteome Res 5:1658-1666   DOI
39 Strasser R, Altmann F, Mach L, Glossl J, Steinkellner H (2004) Generation of Arabidopsis thaliana plants with complex N-glycans lacking beta1,2-linked xylose and core alpha1, 3-linked fucose. FEBS Lett 561:132-136   DOI
40 Shields RL, Namenuk AK, Hong K, Meng YG, Rae J, Briggs J, Xie D, Lai J, Stadlen A, Li B, Fox JA, Presta LG (2001) High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R. J Biol Chem 276:6591-6604   DOI   ScienceOn
41 Tekoah Y, Ko K, Koprowski H, Harvey DJ, Wormald MR, Dwek RA, Rudd PM (2004) Controlled glycosylation of therapeutic antibodies in plants. Arch Biochem Biophys 426:266-278   DOI
42 Ma JKC, Vine ND (1999) Plant expression systems for the production of vaccines. Curr Top Microbiol Immunol 236:275-292   DOI
43 Ma JK, Chikwamba R, Sparrow P, Fischer R, Mahoney R, Twyman RM (2005) Plant-derived pharmaceuticals-the road forward. Trends Plant Sci 10:580-585   DOI
44 Ma JK, Drake PM, Christou P (2003) The production of recombinant pharmaceutical proteins in plants. Nat Rev Genet 4:794-805   DOI
45 Ma JK, Hiatt A, Hein M., Vine ND, Wang F, Stabila P, van Dolleweerd C, Mostov K, Lehner T (1995) Generation and assembly of secretory antibodies in plants. Science 268:716-719   DOI